SRP3030
ENA-78 (8-78) human
recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
Sign Into View Organizational & Contract Pricing
All Photos(1)
CXCL5, Epithelial Neutrophil Activating Peptide-78, LIX (murine)
Recommended Products
biological source
human
recombinant
expressed in E. coli
Assay
≥98% (HPLC)
≥98% (SDS-PAGE)
form
lyophilized
potency
10.0-100.0 ng/mL
mol wt
7.8 kDa
packaging
pkg of 20 μg
technique(s)
cell culture | mammalian: suitable
impurities
<0.1 EU/μg endotoxin, tested
color
white to off-white
UniProt accession no.
shipped in
wet ice
storage temp.
−20°C
Gene Information
human ... CXCL5(6374)
General description
ENA-78 (epithelial cell-derived neutrophil activating peptide-78) is a CXC chemokine that signals through the CXCR2 receptor. It is expressed in monocytes, platelets, endothelial cells, and mast cells. ENA-78 is a chemoattractant for neutrophils. The murine homolog of ENA-78 is called LIX. Three N-terminal truncated variants of human ENA-78; ENA 5-78, ENA 8-78, ENA 9-78, contain 74, 71, and 70 amino acid residues, respectively, possess increased biological activity. ENA-78 contains the four conserved cysteine residues present in CXC chemokines, and also contains the ‘ELR′ motif common to CXC chemokine that bind to the CXCR1 and CXCR2 receptors. Recombinant human ENA-78 is a 7.8 kDa protein consisting of 71 amino acid residues. The ENA-78 gene is mapped to human chromosome 4q13.3.
Biochem/physiol Actions
ENA-78 (epithelial cell-derived neutrophil activating peptide-78) gene expression is associated with sepsis, atherosclerosis, COPD (chronic obstructive pulmonary disease), psoriasis and gastrointestinal inflammation. ENA-78 is angiogenic factor and is associated with cancer progression. Upregulation of ENA-78 gene is observed in non‐small‐cell lung cancer, head, neck, gastric, pancreatic, colorectal, prostate and lung cancer squamous cell carcinoma.
ENA-78 is a CXC chemokine that signals through the CXCR2 receptor. It is expressed in monocytes, platelets, endothelial cells, and mast cells. Recombinant human ENA-78 is a 7.8 kDa protein consisting of 71 amino acid residues.
Sequence
LRELRCVCLQ TTQGVHPKMI SNLQVFAIGP QCSKVEVVAS LKNGKEICLD PEAPFLKKVI QKILDGGNKE N
Physical form
Lyophilized with no additives.
Reconstitution
Centrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/ml. Do not vortex. This solution can be stored at 2-8°C for up to 1 week. For extended storage, it is recommended to further dilute in a buffer containing a carrier protein (example 0.1% BSA) and store in working aliquots at -20°C to -80°C.
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Information
新产品
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
CXCL5 (chemokine (CXC motif) ligand 5).
Atlas of Genetics and Cytogenetics in Oncology and Haematology (2013)
Interleukin?17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment.
Journal of Leukocyte Biology, 76(1), 135-144 (2004)
Chemokine receptors in inflammation: an overview.
Journal of Immunological Methods, 273(1-2), 3-13 (2003)
CXC chemokines in angiogenesis of cancer.
Seminars in Cancer Biology, 14(3), 195-200 (2004)
CXC chemokines in angiogenesis.
Journal of Leukocyte Biology, 68(1), 1-8 (2000)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service